Depression, Anxiety and Sleep in Parkinson's Disease

May 30, 2026 updated by: Aya Noureldin Mohamed, Sohag University

Assessment of Depression , Anxiety and Sleep Disorders in Patients With Idiopathic Parkinson's Disease

This study aims to assess the prevalence and severity of depression, anxiety, and sleep disorders among patients with idiopathic Parkinson's disease. The study will evaluate the relationship between neuropsychiatric symptoms and disease characteristics in order to improve early recognition and patient quality of life.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

100

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients aged 50 years and older with idiopathic Parkinson's disease attending the Neurology Outpatient Clinic and/or admitted to the Neurology Department of Sohag University Hospital. A total of 100 eligible patients will be recruited to assess depression, anxiety, and sleep disorders.

Description

Inclusion Criteria:

Patients diagnosed with idiopathic Parkinson's disease according to the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's Disease (Postuma et al., 2015).

Age ≥ 50 years. Ability to understand and respond to questionnaires and rating scales. Ability and willingness to provide informed consent.

Exclusion Criteria:

Patients with atypical parkinsonism. Patients with a history of other major neurological disorders (e.g., stroke, Alzheimer's disease, multiple sclerosis).

Patients with severe cognitive impairment or dementia that prevents reliable completion of rating scales.

Patients with a current diagnosis of severe psychiatric disorders unrelated to Parkinson's disease (e.g., schizophrenia, bipolar disorder).

Patients with unstable medical conditions. Patients unable or unwilling to provide informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of Depression Severity in Patients with idiopathic Parkinson's Disease
Time Frame: Baseline assessment during study enrollment.
Depression severity measured using the Hamilton Depression Rating Scale (HAM-D). Scores range from 0 to 52, with higher scores indicating more severe depression.
Baseline assessment during study enrollment.
Assessment of Anxiety Severity in Patients with idiopathic Parkinson's Disease
Time Frame: Baseline
Anxiety severity measured using the Hamilton Anxiety Rating Scale (HAM-A). Scores range from 0 to 56, with higher scores indicating more severe anxiety.
Baseline
Assessment of Sleep Disturbance in Patients with idiopathic Parkinson's Disease
Time Frame: Baseline
Sleep disturbance measured using the Parkinson's Disease Sleep Scale (PDSS). Higher scores indicate better sleep quality and fewer sleep-related symptoms.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

February 28, 2027

Study Completion (Estimated)

May 31, 2027

Study Registration Dates

First Submitted

May 24, 2026

First Submitted That Met QC Criteria

May 30, 2026

First Posted (Actual)

June 3, 2026

Study Record Updates

Last Update Posted (Actual)

June 3, 2026

Last Update Submitted That Met QC Criteria

May 30, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Soh-Med-26-5-4MS

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson's Disease

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe